Author Title [ Type(Desc)] Year
Filters: Author is Chang, Yun  [Clear All Filters]
Journal Article
Chang Y, Cai X, Syahirah R, Yao Y, Xu Y, Jin G, Bhute VJ, Torregrosa-Allen S, Elzey BD, Won Y-Y, et al. CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. Nat Commun. 2023;14(1):2266.
Jung J, Chang Y, Jin G, Deng Q, Lian XLance, Bao X. Chemically defined generation of human definitive hematopoietic stem and progenitor cells. STAR Protoc. 2022;4(1):101953.
Chang Y, Syahirah R, Oprescu SN, Wang X, Jung J, Cooper SH, Torregrosa-Allen S, Elzey BD, Hsu AY, Randolph LN, et al. Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells. Biomaterials. 2022;285:121569.
Harris JD, Chang Y, Syahirah R, Lian XLance, Deng Q, Bao X. Engineered anti-prostate cancer CAR-neutrophils from human pluripotent stem cells. J Immunol Regen Med. 2023;20.
Chang Y, Jin G, Luo W, Luo Q, Jung J, Hummel SN, Torregrosa-Allen S, Elzey BD, Low PS, Lian XLance, et al. Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioact Mater. 2023;27:168-180.
Dong T, Zhang S, Chang Y, Bai R, Jiang Y, Ma S, Li Y'nan, Jiang HFeng, Lu W-J. The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system. Stem Cell Res. 2021;51:102196.
Liu X, Zhang S, Chang Y, Wu F, Bai R. Establishment of a KCNQ1 homozygous knockout human embryonic stem cell line by episomal vector-based CRISPR/Cas9 system. Stem Cell Res. 2021;55:102467.
Chang Y, Hellwarth PB, Randolph LN, Sun Y, Xing Y, Zhu W, Lian XLance, Bao X. Fluorescent Indicators for Continuous and Lineage-Specific Reporting of Cell Cycle Phases in Human Pluripotent Stem Cells. Biotechnol Bioeng. 2020.
Hang C, Song Y, Wu F, Dong T, Jiang M, Saleem A, Zhang S, Chang Y, Lu W, Cui M. Generation of a homozygous COX6A2 knockout human embryonic stem cell line (WAe009-A-47) via an epiCRISPR/Cas9 system. Stem Cell Res. 2021;50:102152.
Jiang Y, Li X, Guo T, Lu W-J, Ma S, Chang Y, Song Y, Zhang S, Bai R, Wang H, et al. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 2022.